HOME >> MEDICINE >> NEWS
Light-weight heparin has heavy-weight results in heart attack treatment

DALLAS, Heart attack patients treated with the blood-thinner enoxaparin a low molecular weight heparin plus a clot dissolver were significantly less likely to die or have repeat heart attacks within 30 days compared to patients who received unfractionated heparin (UFH), according to a Rapid Track article in todays Circulation: Journal of the American Heart Association.

Patients in the study had what are known as ST-segment elevation myocardial infarctions, which are the most severe type of heart attack. We have very encouraging data but the evidence is not yet sufficient to say that enoxaparin should be standard treatment for severe heart attacks, says Elliott Antman, M.D., associate professor of medicine at Harvard Medical School and director of the coronary care unit of Brigham and Womens Hospital in Boston. However, the data suggest we should pursue a larger clinical trial.

Enoxaparin previously has been shown to be superior to unfractionated heparin (another blood thinner) for patients with milder heart attacks (non-ST segment elevation). It can be given as a simple injection, rather than the continuous infusion required with UFH, and it does not require frequent testing of the patients blood clotting status.

The researchers report their findings from the ENTIRE-TIMI 23 study. This international study involved 483 patients who presented with severe heart attacks at hospitals in the United States and Europe. Participants were randomly assigned either standard reperfusion with a full dose of the clot-dissolving drug tenecteplase (TNK) or combination therapy with abciximab and a half dose of TNK and either unfractionated heparin (UFH) or enoxaparin. Abciximab is a drug that helps keep blood platelets from sticking together to form clots.

The study was designed to evaluate enoxaparin as adjunctive treatment with various forms of reperfusion therapies (TNK, abciximab). To evaluate reperfusion (blood flow) researchers used the TIMI
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
4-Mar-2002


Page: 1 2

Related medicine news :

1. The protective effects of heparin in preventing miscarriages in lupus patients
2. Newer formulation of heparin improves outcomes for suspected heart attack patients
3. New studies show mixed results on epilepsy drugs and birth defects
4. Study of obese diabetics explains why low-carb diets produce fast results
5. Sharing clinical trial results with participants may be beneficial
6. Emergency clopidogrel could save thousands of lives46,000-patient heart attack trial results
7. Similar results found in both older and younger patients undergoing weight-loss surgery
8. OHSU researcher says FDA could broaden access to results of clinical drug trials
9. Kinder, gentler procedure gives superior results for stem cell transplants
10. Good results with only one egg in in-vitro fertilization
11. Holiday feasting could sabotage liposuction results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2020)... ... January 10, 2020 , ... WellHaven Pet Health, a ... in a new online community coming in February 2020, LEAD WELL with WOMEN. The ... Wellbeing Village. , The vision of LEAD WELL with WOMEN is to empower women, ...
(Date:1/10/2020)... ... January 10, 2020 , ... SMG3Rx, a clinical ... be attending the HIMSS (Healthcare Information and Management Systems Society) Global Conference & ... health information and technology event of the year, where professionals throughout the global ...
(Date:1/8/2020)... ... January 08, 2020 , ... ... sciences teams, announced today that the company is rebranding as Red Nucleus R&D, ... and performance solutions for the life sciences industry. , The addition of ...
(Date:1/8/2020)... ... January 09, 2020 , ... Real ... Webinar, Thursday, Jan. 23, 2020 • 1:30-3:00 p.m. EST, https://www.centerwatch.com/rweanddata ... (RWD) to generate evidence and identify gaps and challenges when conducting trials? The ...
(Date:1/7/2020)... ... January 07, 2020 , ... G-CON Manufacturing, ... to the company’s 200,000 sq. ft. manufacturing site in College Station, TX. The ... dedicated to POD architectural, mechanical, electrical and automation fit out. , “This facility ...
Breaking Medicine News(10 mins):
(Date:1/8/2020)... Mich. (PRWEB) , ... January 08, 2020 , ... ... leader in FDA compliance consulting, is proud to announce the attainment of a ... Council, a regional certifying partner of the Women’s Business Enterprise National Council (WBENC). ...
(Date:1/8/2020)... ... January 09, 2020 , ... ... partner practices a complimentary freezer program. The cryogenic freezer allows practices to have ... top stem cell and exosome biologics require cryogenic freezing. This may include a ...
(Date:1/7/2020)... ... 2020 , ... Myant Inc., the pioneers in Textile Computing™, will be showcasing ... CES 2020 (January 7-10, Las Vegas), including apparel from the Skiin Connected Health & ... of the CES 2020 Innovation Awards. , While electrocardiography, or the study of the ...
Breaking Medicine Technology:
Cached News: